Codiak BioSciences, Inc. SEC Filings

Filed On	Filing
14 Feb 2024	SC 13G/A
02 May 2023	25-NSE
10 Apr 2023	SC 13G/A
30 Mar 2023	Form 4: Howze Yalonda, See Remarks Sold 1,628 shares ($318)
30 Mar 2023	Form 4: Sathyanarayanan Sriram, Chief Scientific Officer Sold 11,762 shares ($1.94K)
30 Mar 2023	Form 4: Konstantinov Konstantin, Chief Technology Officer Sold 9,364 shares ($1.87K)
30 Mar 2023	Form 4: Bain Linda, Chief Financial Officer Sold 13,412 shares ($2.27K)
30 Mar 2023	Form 4: Barna Nicole, See Remarks Sold 7,305 shares ($1.21K)
30 Mar 2023	Form 4: Williams Douglas E, Director Sold 41,667 shares ($7.5K)
29 Mar 2023	NT 10-K
29 Mar 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
27 Mar 2023	8-K: Bankruptcy or Receivership; Costs Associated with Exit or Disposal Activities +2 more
03 Mar 2023	SC 13G/A
21 Feb 2023	Form 4: Bain Linda, Chief Financial Officer Received 7,613 shares by exercise or conversion · Sold 2,364 shares ($5.23K) · Received 7,613 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Williams Douglas E, Director Received 22,969 shares by exercise or conversion · Sold 7,112 shares ($15.7K) · Received 22,969 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Konstantinov Konstantin, Chief Technology Officer Received 4,200 shares by exercise or conversion · Sold 1,308 shares ($2.89K) · Received 4,200 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Bernstein Karen, Director Received 8,750 shares by exercise or conversion
21 Feb 2023	Form 4: Haddock Jason, Director Received 8,750 shares by exercise or conversion
21 Feb 2023	Form 4: Sathyanarayanan Sriram, Chief Scientific Officer Received 7,350 shares by exercise or conversion · Sold 2,283 shares ($5.05K) · Received 7,350 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Gillis Steven, Director Received 8,750 shares by exercise or conversion

Comments